C R Divgi
Impact in
- Oncology top 10%
- Peptidase Inhibition and Analysis
- HER2/EGFR in Cancer Research
-
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Radiopharmaceutical Chemistry and Applications 6
- Monoclonal and Polyclonal Antibodies Research 4
- Oncology 6
- Peptidase Inhibition and Analysis 3
- Lung Cancer Research Studies 1
- Co-authors
- Steven M. Larson (3 shared papers)S Welt (3 shared papers)Ronald D. Finn (3 shared papers)E A Carswell (2 shared papers)Andrew M. Scott (3 shared papers)Lloyd J. Old (2 shared papers)Alfred Cohen (1 shared paper)Pilar Garin‐Chesa (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)International Journal of Oncology (1 paper)Seminars in Nuclear Medicine (1 paper)Molecular Imaging and Biology (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United StatesNetherlandsItaly
In The Last Decade
C R Divgi
11 papers receiving 571 citations
Peers
Comparison fields: 5 of 52
- Oncology 278
- Radiology, Nuclear Medicine and Imaging 213
- Cancer Research 100
- Pulmonary and Respiratory Medicine 117
- Biotechnology 26
Countries citing papers authored by C R Divgi
This map shows the geographic impact of C R Divgi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C R Divgi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C R Divgi more than expected).
Fields of papers citing papers by C R Divgi
This network shows the impact of papers produced by C R Divgi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C R Divgi. The network helps show where C R Divgi may publish in the future.
Co-authors
The 25 scholars most cited alongside C R Divgi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 208 | |
| 2 | 1993 | 140 | |
| 3 | 1989 | 81 | |
| 4 | 2007 | 25 | |
| 5 | 1989 | 24 | |
| 6 | Status of radiolabeled monoclonal antibodies for diagnosis and therapy of cancer. | 1996 | 23 |
| 7 | Novel investigative approaches for advanced renal cell carcinoma. | 2000 | 22 |
| 8 | 1998 | 21 | |
| 9 | 2015 | 19 | |
| 10 | Pilot radioimmunotherapy trial with 131I-labeled murine monoclonal antibody CC49 and deoxyspergualin in metastatic colon carcinoma. | 1995 | 19 |
| 11 | 2006 | 2 |
About C R Divgi
C R Divgi is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Pharmaceutical Science, having authored 11 papers that have together received 584 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Peptidase Inhibition and Analysis (3 papers), Lung Cancer Research Studies (1 paper), Glycosylation and Glycoproteins Research (1 paper), Lung Cancer Treatments and Mutations (1 paper), Renal cell carcinoma treatment (1 paper) and Gastric Cancer Management and Outcomes (1 paper). The work is most often cited by research in Oncology (278 citations), Radiology, Nuclear Medicine and Imaging (213 citations), Cancer Research (100 citations), Pulmonary and Respiratory Medicine (117 citations) and Biotechnology (26 citations). C R Divgi has collaborated with scholars based in United States, Netherlands and Italy. Frequent co-authors include Steven M. Larson, S Welt, Ronald D. Finn, E A Carswell, Andrew M. Scott, Lloyd J. Old, Alfred Cohen, Pilar Garin‐Chesa, Martin C. Graham and Gert Jan Fleuren. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Oncology, Seminars in Nuclear Medicine, Molecular Imaging and Biology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.